DRG’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key gastric cancer patient populations covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download. Use the extended worldwide coverage data set to:

  • View 10-year forecasts of the first-line drug-treatable population and diagnosed adenocarcinoma incident cases for all 171 countries, stratified by region and World Bank income status.
  • Aggregate country-level estimates into region-level estimates, according to user preference or as required by regulators for orphan drug designations.
  • Visualize global correlations between disease risk or patient population size and key indicators of market opportunity such as GDP per capita and healthcare spend per capita.
  • Generate and export global heat maps of disease risk or patient population size.

The extended worldwide coverage dashboard is available as an Excel file in the “Downloads” section. It is available only to clients with subscriptions to all 45 countries covered by DRG Epidemiology. For subscription and entitlement queries, please contact questions@teamdrg.com.

Table of contents

  • Extrapolated Worldwide Coverage
    • Extrapolated Worldwide Coverage
      • Gastric Cancer Extrapolated Worldwide Coverage

Author(s): Mudasir Khan, M.P.H; Abey John, MPH

Mudasir works as an associate epidemiologist within the epidemiology team at Decision Resources Group. He specializes in developing epidemiological forecasts for multiple indications within the DRG syndicated portfolio. Mudasir holds a masters in public health specializing in epidemiology from TISS, Mumbai.

Abey John is a medical graduate with a Master’s in Public Health and has been associated with DRG since September 2015. He works with a global team of epidemiologists in performing systematic reviews of assigned diseases and prepare forecast models for clients. He also is involved in producing analyses for pharmaceutical drug developers on the descriptive epidemiology of major drug indications in mature and developing markets and have an overall experience of three years working in different healthcare sectors across the country. Prior to joining DRG, Abey had been working with Jhpiego (an affiliate of Johns Hopkins Medical University) in implementing Family Planning Health Programs in India with collaborating with the Government of India. He also has worked with a grassroots level NGO as a health team manager which worked for the benefit of the rural population living in the foothills of the Himalayas.


Related Reports

Gastroesophageal Cancer | Geographic Focus - China | Gastric Cancer - China In-Depth - China

MARKET OUTLOOK China has the highest incidence of gastric cancer (gastric and gastroesophageal junction adenocarcinoma) in the world, and therapeutic options are limited...

View Details

Gastric Cancer | Epidemiology | Emerging Markets

DRG Epidemiology's coverage of gastric cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We re...

View Details

Gastric Cancer | Epidemiology | Americas

DRG Epidemiology's coverage of gastric cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We re...

View Details

Gastric Cancer | Epidemiology | Europe

DRG Epidemiology's coverage of gastric cancer comprises epidemiological estimates of key patient populations across 45 countries worldwide. We re...

View Details